mynth
← DATABASE
10/2023

VETPARTNERS acquired by EQT PARTNERS

AUSTRALIA Health Providers / Outpatient Care / Vet Clinics EV 1b - 4b AUD

Context

EQT, through its BPEA Fund VIII, agreed to acquire VetPartners from National Veterinary Associates (NVA), a portfolio company of JAB Holding. The transaction represents a major entry for EQT into the ANZ veterinary services market, following its extensive track record with IVC Evidensia in Europe. The strategic objective is to consolidate VetPartners' leadership position through significant capital investment in digital tools, advanced diagnostic equipment, and recruitment initiatives. The deal was finalized through a fast-tracked auction process where EQT was selected as the preferred bidder over rival private equity firms. Under EQT's ownership, the group will continue its aggressive expansion across the fragmented Australasian market while enhancing its specialized veterinary training centers and managed services division (United Vets Group).

VETPARTNERS, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2016, VetPartners is the leading veterinary service provider in Australia and New Zealand, with a growing presence in Singapore. The group operates a network of approximately 267 community-based general practice clinics and specialty hospitals. It employs over 1,300 veterinarians and 3,000 nurses, facilitating more than 3.2 million pet visits annually. The company utilizes a "Join Us, Stay You" decentralized model that allows local clinics to maintain their brand identity and clinical autonomy while benefiting from centralized business support and high-tech infrastructure.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (AUD)

Year
Rev
EBITDA
EBIT
2023
LOGIN
LOGIN
LOGIN
2022
LOGIN
LOGIN
LOGIN

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
DateAcquirerTargetCountrySectorDeal Context
12/2023ESSLING CAPITALX-RAY PHOCEAFRANCEHealth Providers

X-Ray Phocea, a leading medical imaging group in Southern France, has secured a strategic minority investment from Essling Expansion, alongside Bpifrance and SOFIPACA. Despite this new capital entry, the majority of the group�s shareholding remains in the hands of its 20 associate radiologists, preserving a practitioner-led management model.

12/2023ANDERA PARTNERSGROUPE IMAGERIE CARDINETFRANCEHealth Providers

Andera Acto is providing minority financing to Imagerie Cardinet to support its next phase of expansion. The transaction is structured to allow the associate radiologists to maintain a massive majority, representing approximately 95% of the capital. This strategic funding provides the group with a development envelope of nearly EUR100 million to finance external growth. The investment strategy aims to reinforce the group's presence in the Paris region and initiate its expansion on a national scale, with several new centers expected to join by the end of the year

08/2023QUADRIVIO GROUPTHE PRIVATE CLINIC (TPC)UNITED KINGDOMHealth Providers

Quadrivio Group has acquired a majority stake in The Private Clinic from BlueGem Capital Partners to serve as a platform for its "Silver Economy" strategy. The industrial logic is anchored in the "healthy longevity" megatrend: as the population ages, demand for aesthetic and wellness treatments among the affluent over-50s is booming. The transaction was structured as a simultaneous "Buy-and-Build" play, as TPC acquired four smaller clinics specializing in cosmetic medicine at closing to immediately scale its footprint

08/2023BAIN CAPITALESTIA HEALTHAUSTRALIAHealth Providers

Following a five-month bidding process, Bain Capital has entered into a definitive Scheme Implementation Agreement to acquire 100% of the share capital of Australian aged care operator Estia Health Limited. The public-to-private transaction is structured under a board-endorsed scheme of arrangement that permits the target to distribute fully franked dividends to eligible shareholders prior to the transaction's close. For the acquirer Bain Capital, the transaction expands its dedicated healthcare portfolio, leveraging a global platform that encompasses over 175 platform investments in the medical and care sectors

07/2023MEDIAN KLINIKENHESTIA ALLIANCESPAINHealth Providers

MEDIAN Group, backed by Waterland Private Equity, acquired Hestia Alliance, one of Spain's largest private post-acute and mental health care providers, marking MEDIAN's first entry into the Spanish healthcare market. The transaction received regulatory approval prior to the public announcement. The acquisition is part of MEDIAN's continued internationalisation strategy following its earlier expansion into the UK through the acquisition of Priory Group in 2021. The combination of MEDIAN, Priory, and Hestia creates a pan-European post-acute and mental health platform spanning Germany, the United Kingdom, and Spain

06/2023PARQUEST CAPITALIMANEOFRANCEHealth Providers

Parquest acquired a majority stake in the newly formed Imaneo group from its 70 associate radiologists. The transaction was the result of a competitive process involving both French and international private equity funds, as well as corporate interest from the life sciences sector. This strategic operation facilitates the merger of three independent radiology practices into a single unified platform. The associate radiologists, who were already shareholders in their respective legacy firms, reinvested significantly to retain nearly 50% of the new group's capital

06/2023ARDIANMON VETOFRANCEHealth Providers

Ardian acquired a minority stake (approximately 20%) in Mon Veto through a primary capital increase. This "pure cash-in" operation was designed to strengthen the group's equity base without any cash-out for the founding veterinarians. The transaction supports Mon Veto's aggressive buy-and-build strategy in a rapidly consolidating European market. The partnership aims to accelerate the group's domestic expansion and facilitate its entry into highly fragmented international markets, such as Italy and Spain

11/2022RADNETHEART & LUNG IMAGINGUNITED KINGDOMHealth Providers

RadNet, a US-based medical imaging specialist, has acquired a 75% majority stake in Heart & Lung Imaging Limited (HLH), a UK-based teleradiology network focused on detecting and diagnosing lung and cardiovascular diseases. This move is part of RadNet's strategy to enhance its capabilities in early cancer detection and develop solutions that combine artificial intelligence (AI) with specialized medical expertise. Through this acquisition, RadNet expands its presence in the UK and positions itself in a market with significant growth prospects, driven in part by the National Health Service's (NHS) Targeted Lung Health Check (TLHC) program

10/2022CBPE CAPITALVEINCENTREUNITED KINGDOMHealth Providers

CBPE Capital has completed a majority investment in Veincentre, acquiring the stake previously held by Palatine Private Equity alongside the company,s founders. This transaction marks a secondary LBO for the specialist clinic group, which saw significant growth under Palatine,s three-year ownership, including the expansion from 7 to 22 clinics. The deal was structured to support the current management team, led by CEO Maurice McLoughlin, in the next phase of their national expansion strategy. The rationale for the acquisition is rooted in the high demand for specialized outpatient vascular services in the UK and Veincentre,s proven, scalable clinical model

09/2022ORADIANSEREVELFRANCEHealth Providers

Oradianse, a leading group of radiologists, has acquired a radiology practice in Revel, located in the Haute-Garonne region near Toulouse. This move is part of the company's territorial development strategy, aimed at strengthening its presence in the Occitanie region and consolidating its national network of medical imaging centers. The practice, previously owned by Dr. Gazel since 2019, was seeking a successor to ensure continuity of care for patients in the area as Dr. Gazel prepares for retirement

REFERENCES

Valuation range: EV 1b - 4b AUD

Revenue range: 450M - 900M AUD

EBITDA range: 100M - 200M AUD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VETPARTNERS by EQT PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Acquirer: eqt partners